The application of glutamine and growth hormone in patients undergoing liver transplantation

JIANG Tao,WANG Xuan,ZHANG Bin,LU Lei,ZHANG Dong-hua,LI Zeng-cai,WANG Yue-hua,JIA Shao-chang
DOI: https://doi.org/10.3969/j.issn.1007-810X.2011.02.003
2011-01-01
Abstract:Objective: To explore the effects of glutamine(Gln) and growth hormone(GH) on the metabolism of protein,immunofunction,infection and acute rejection in patients undergoing liver transplantation.Methods: Sixty patients were prospectively randomized to study group enriched with Gln(alanyl-glutamine dipeptide 100 ml(20g)/day and GH(recombined human GH 9 U/day) or control group.All Patients received isocaloric 20-25 kcal/(kg·d) and isonitrogenous 0.16 g/(kg·d) nutrition after operation for 14 days.The serum levels of albumin(ALB),prealbumin(PA),transferrin(TF) and blood CD4/CD8 ratio were measured on the 2nd day,the 9th day and the 16th day after transplantation respectively.Results: PA and TF levels of the study group were significantly higher than the control group on the 9th day and the 16th day.CD4/CD8 ratio of the study group increased significantly.The incidence rate of infection(13.3%) of the study group was significantly lower than the control(40.0%),while the incidence rate of acute rejection had no significant difference between the two groups.Conclusion: The application of Gln and GH in patients undergoing liver transplantation can improve metabolism of protein,enhance the immunofunction,lower the incidence rate of infection and does not increase the incidence rate of acute rejection.
What problem does this paper attempt to address?